Axtriol-B Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per g Calcipotriol monohydrate 50 mcg, betamethasone dipropionate 0.5 mg

Indications/Uses

Topical treatment of scalp & non-scalp plaque psoriasis vulgaris in adults.

Click to view Axtriol-B detailed prescribing information

Dosage/Direction for Use

Apply to affected areas once daily. Recommended treatment period: 4 wk for scalp areas & 8 wk for non-scalp areas. Max daily dose: 15 g. Max treated area: 30% BSA. Affected scalp areas 1-4 g daily.

Click to view Axtriol-B detailed prescribing information

Overdosage

View Axtriol-B overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Ca metabolism disorders; viral skin lesions (eg, herpes or varicella), fungal or bacterial skin infections, parasitic infections, skin TB manifestations, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris & rosacea, rosacea, ulcers & wounds; erythrodermic, exfoliative & pustular psoriasis.

Click to view Axtriol-B detailed prescribing information

Special Precautions

Discontinue use if infection worsens. Risk of hypercalcaemia if max daily dose is exceeded & generalised pustular psoriasis or rebound effects upon discontinuation; guttate psoriasis. Not to be used on sensitive areas (face & genitals) & wash hands after each application to avoid accidental transfer. Avoid application under occlusive dressings, on large areas of damaged skin, on mucous membranes or in skin folds. May cause local skin reactions (eg, contact dermatitis) or irritation to eyes & mucous membranes due to butylated hydroxytoluene. Limit or avoid excessive exposure to either natural or artificial sunlight. Long-term use. Avoid concurrent use w/ other steroids. Combination w/ other anti-psoriatic products. Severe renal insufficiency or hepatic disorders. Avoid use during 1st trimester of pregnancy. Not to be used during lactation. Childn <18 yr.

Click to view Axtriol-B detailed prescribing information

Use In Pregnancy & Lactation

Click to view Axtriol-B detailed prescribing information

Adverse Reactions

Pruritus.

Click to view Axtriol-B detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Axtriol-B detailed prescribing information

Storage

View Axtriol-B storage conditions for details to ensure optimal shelf-life.

Description

View Axtriol-B description for details of the chemical structure and excipients (inactive components).

Action

View Axtriol-B mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Psoriasis, Seborrhea & Ichthyosis Preparations

ATC Classification

D05AX52 - calcipotriol, combinations ; Belongs to the class of other antipsoriatics for topical use.

Regulatory Classification

Presentation/Packing

Form

Axtriol-B topical gel

Packing/Price

15 g x 1's;30 g x 1's

Axtriol-B

betamethasone + calcipotriol

Manufacturer:

Hoe Pharma

Distributor:

Zuellig Pharma